Autologous recovery following non-myeloablative unrelated donor bone marrow transplantation for severe aplastic anaemia

Annals of Hematology

Volumn 81, Issue 7, 2002, Pages 378-381

  Elebute, M O ^a   Ball, S E ^a   Gordon Smith, E C ^a   Sage, D ^b   Marsh, J C W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b South Thames Blood Centre   (United Kingdom)

Author keywords

Aplastic anaemia; Bone marrow transplant; Non myeloablative regimen; Unrelated donor

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYELOABLATIVE AGENT; OXYMETHOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ALLELE; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LIVING DONOR; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TRANSFUSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MYCOSES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 0036943740     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0467-2     Document Type: Article

References (24)

1. Camitta BM, Thomas ED, Nathan DG, et al. (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63-70
2. Hows J, Stone JV, Camitta BM (2000) Alternative bone marrow transplantation for severe acquired aplastic anaemia. In: Schrezenmeier H, Bacigalupo A (eds) Aplastic anaemia: pathophysiology and treatment. Cambridge University Press, Cambridge, pp 258-274
3. Gluckman E, Horowitz MM, Champlin RE, et al. (1992) Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79:269-275
4. Bacigalupo A, Hows J, Gordon-Smith EC, et al. (1988) Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant 3:531-535
5. Young N, Griffith P, Brittain E, et al. (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861-1869
6. Podesta M, Piaggio G, Frassoni F, et al. (1998) The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia. Blood 91:1959-1965
7. Schrezenmeier H, Marin P, Raghavachar A, et al. (1993) Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 85:371-377
8. Tichelli A, Gratwohl A, Wursch A, et al. (1988) Late haematological complications in severe aplastic anaemia. Br J Haematol 69:413-418
9. Tichelli A, Gratwohl A, Nissen C, et al. (1994) Late clonal complications in severe aplastic anemia. Leuk Lymphoma 12:167-175
10. Storb R, Thomas ED, Buckner CD, et al. (1984) Marrow transplantation for aplastic anemia. Semin Hematol 21:27-35
11. Hows JM, Yin JL, Marsh J, et al. (1986) Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 68:1322-1328
12. Camitta B, Ash R, Menitove J, et al. (1989) Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood 74:1852-1857
13. Margolis D, Camitta B, Pietryga D, et al. (1996) Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 94:65-72
14. Deeg HJ, Seidel K, Casper J, et al. (1999) Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 5:243-252
15. Santamaria P, Reinsmoen NL, Lindstrom A, et al. (1994) Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 83:3834
16. Tiercy JM, Djavad N, Rufer N, et al. (1994) Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Immunol 41:207-215
17. Scott I, O'Shea J, Bunce M, et al. (1998) Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 92:4864-4871
18. Prasad VK, Kernan NA, Heller G, et al. (1999) DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood 93:399-409
19. Camitta BM, Thomas ED, Nathan DG, et al. (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504-514
20. Tichelli A, Passweg J, Nissen C, et al. (1998) Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol 100:393-400
21. McCann SR, Bacigalupo A, Gluckman E (1993) Mixed chimerism: detection and significance following bone marrow transplantation. Bone Marrow Transplant 11:91-94
22. McCann SR, Passweg JR, Storb R, et al. (2000) HLA identical sibling bone marrow transplantation to treat severe aplastic anaemia. In: Schrezenmeier H, Bacigalupo A (eds) Aplastic anaemia: pathophysiology and treatment. Cambridge University Press, pp 230-257
23. Brodsky RA, Sensenbrenner LL, Jones RY (1996) Complete remission in aplastic anaemia after high dose cyclophosphamide without bone marrow transplantation. Blood 87:491
24. Tisdale JF, Dunn DE, Geller N, et al. (2000) High dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 256:1554